FREMONT, CA / ACCESS Newswire / January 27, 2026 / Aehr Test Systems (NASDAQ:AEHR), a leading provider of test and burn-in solutions for semiconductor devices used in artificial intelligence (AI), data center, automotive, and industrial applications, today announced it will participate in the Oppenheimer 11th Annual Emerging Growth Conference being held virtually February 3-4, 2026. Aehr Test CEO Gayn Erickson and CFO Chris Siuwill be hosting virtual meetings with investors throughout the day on Tuesday, Fe ...

Aehr Test Systems semiconductor burn-in rack with wafers inside, signaling AI chip testing demand. Key Points Aehr Test Systems has soared in the first weeks of 2026, with the catalyst being the firm's latest earnings. While the EV market puts pressure on sales, the company is seeing strong momentum in AI-driven demand. Aehr's opportunity is large, but uncertainty and a high valuation still cloud the stock's outlook. Interested in Aehr Test Systems? Here are five stocks we like better. For shares ...

Summary of Aehr Test Systems FY Conference Call Company Overview - **Company**: Aehr Test Systems (NasdaqCM: AEHR) - **Industry**: Semiconductor Testing - **Focus**: Reliability and burn-in testing for semiconductor devices, particularly in the context of data centers and AI processors [1][2] Key Points and Arguments Business Operations - Aehr Test Systems has been in the semiconductor test business for nearly 50 years, specializing in reliability and burn-in testing [1] - The company offers both package-level and wafer-level burn-in systems, with a unique capability in wafer-level testing [2] - The company has a large facility in Fremont, California, which serves as the final assembly and testing site for its products [2] Market Demand and Capacity - Aehr can ship upwards of 20 systems per month for both wafer-level and package-level burn-in, indicating significant production capacity [3] - The installed base includes major players in AI processors, automotive, and data centers, contributing to a growing market demand [4] - The company has seen a shift in revenue sources, moving from over 90% reliance on silicon carbide to new markets such as AI processors and memory technologies [18] Financial Projections - The company anticipates a significant increase in bookings from approximately $20 million in the first half to between $60 and $80 million in the second half of the fiscal year [12] - The average selling price (ASP) for systems is estimated to be between $5 million and $6 million each, which could lead to substantial revenue growth [8] Technological Advancements - Aehr has introduced full automation in its Sonoma system, reducing overhead time between burn-in cycles to just two minutes [13] - The company has developed proprietary technologies, including patented wafer packs, which enhance the efficiency and effectiveness of the burn-in process [9][10] Strategic Partnerships - Aehr has partnered with ASE ISE, the largest OSAT in the world, to expand its capabilities in wafer-level burn-in for high-temperature operating life tests [14] - The company is engaged with multiple leading AI processor suppliers to evaluate wafer-level burn-in solutions [29] Market Trends - The demand for reliability in AI and automotive applications is increasing, with a focus on reducing failure rates in critical systems [25][26] - The company is observing a growing trend towards wafer-level burn-in as a cost-effective solution compared to traditional testing methods [27] Competitive Landscape - Aehr differentiates itself by providing functional testing within its burn-in systems, ensuring a valid production burn-in process [19] - The company is not pursuing commoditized markets like standard CPUs or mobile devices, focusing instead on high-value applications in AI and automotive sectors [32] Additional Important Insights - The semiconductor testing market is projected to grow, with 2%-5% of device market dollars typically spent on testing [18] - Aehr's revenue model includes a mix of system sales and consumables, with higher margins on wafer-level products compared to package-level consumables [23] - The company is cautious about pricing strategies, aiming to establish a strong market presence before adjusting prices [22] This summary encapsulates the key insights from the Aehr Test Systems FY Conference Call, highlighting the company's strategic direction, market opportunities, and technological advancements in the semiconductor testing industry.

Aehr Test Confidential Setting the Test Standard for Tomorrow Setting the Test Standard for Tomorrow January 2026 Nasdaq: AEHR Aehr Test Systems Company Overview Semiconductor Test & Burn-in for over 45 Years! XP High Power Test & Burn-In System Medium Power Test & Burn-In System Single Wafer Stepping Test & Burn-In System l Worldwide leader in wafer-level test and burn-in systems l Unique full-wafer test and burn-in systems and contactors l Technology leader in massively parallel and high-power test and bu ...

Revenue Performance - For the three months ended November 28, 2025, revenues decreased by $3.6 million (27%) to $13.5 million, primarily due to lower shipments of contactors amid soft demand for electric vehicles [93]. - For the six months ended November 28, 2025, revenues decreased by $5.7 million (22%) to $20.9 million, with contactors revenue down by $14.6 million, partially offset by an increase in systems revenue of $8.3 million [94]. Profitability - Gross profit for the three months ended November 28, 2025, decreased by $2.9 million (53%) to $2.5 million, with gross margin dropping by 14.4 percentage points to 25.7% [98]. Expenses - Research and development expenses increased by $0.7 million (31%) for the three months ended November 28, 2025, totaling $3.0 million, representing 30.1% of total revenues [100]. - Selling, general and administrative expenses remained consistent at $4.4 million for the three months ended November 28, 2025, accounting for 44.9% of total revenues [101]. Interest and Tax - Interest income, net, decreased by $34,000 (15%) for the three months ended November 28, 2025, totaling $194,000, primarily due to lower average cash balances [107]. - The company recognized an income tax benefit of $1.2 million for the three months ended November 28, 2025, compared to a benefit of $217,000 in the prior year, reflecting losses in the United States [110]. Cash and Cash Flow - Cash, cash equivalents, and restricted cash were $31.0 million as of November 28, 2025, down from $35.2 million as of November 29, 2024 [114]. - Operating activities resulted in a cash outflow of $1.5 million for the six months ended November 28, 2025, compared to an outflow of $3.5 million in the prior year [115]. - The net increase in cash, cash equivalents, and restricted cash was $4.5 million for the six months ended November 28, 2025, compared to a decrease of $14.1 million in the prior year [115]. - Cash flows from operating activities increased by $2.0 million for the six months ended November 28, 2025, compared to the same period in the prior year [116]. - Net cash used in investing activities decreased by $7.5 million for the six months ended November 28, 2025, primarily due to a $10.6 million payment for the acquisition of Incal in the prior period [117]. - Net cash provided by financing activities increased by $9.1 million for the six months ended November 28, 2025, driven by net proceeds of $9.4 million from the issuance of common stock [118]. Off-Balance Sheet and Market Risk - There are no off-balance sheet arrangements or undisclosed borrowings reported by the company [119]. - The company is not required to provide quantitative and qualitative disclosures about market risk as a smaller reporting company [120].

Core Insights - Aehr Test Systems reported a decline in net revenue to $9.9 million for Q2 fiscal 2026, down from $13.5 million in the same quarter of the previous year, indicating financial challenges [1][6] - The company experienced a GAAP net loss of $3.2 million, or $0.11 per diluted share, compared to a loss of $1.0 million, or $0.03 per diluted share, in the prior year [2] - Despite current financial difficulties, Aehr anticipates bookings between $60 million and $80 million in the second half of the fiscal year, suggesting potential for strong growth in fiscal 2027 [3][6] Financial Performance - Gross profit for the quarter was reported at $2.55 million, but the company faced an operating loss of $4.87 million [1] - Non-GAAP net loss was $1.3 million, or $0.04 per diluted share, contrasting with a non-GAAP net income of $0.7 million, or $0.02 per diluted share, in the previous year [2] - EBITDA for the quarter was a negative $5.37 million, reflecting the financial strain the company is under [2] Market Position and Strategy - Aehr is expanding its presence in wafer-level burn-in (WLBI) and packaged-part burn-in (PPBI) segments, with increased engagements and production installations across multiple markets [3] - The company is diversifying into markets such as AI processors, gallium nitride power semiconductors, and silicon photonics integrated circuits, which is expected to expand its total addressable market [4] - Aehr reinstated its guidance for the second half of fiscal 2026, expecting revenue between $25 million and $30 million and a non-GAAP net loss per diluted share between $0.09 and $0.05 [4] Analyst Outlook - Craig-Hallum maintained a "Hold" rating for Aehr Test Systems, with the stock priced at approximately $24.30, reflecting a cautious outlook on the company's financial performance [5] - The company is positioning itself for future growth through strategic partnerships and increased demand for its new Sonoma ultra-high-power PPBI systems [5]

Core Viewpoint - Craig-Hallum has lowered the price target for Aehr Test Systems (AEHR) to $21 from $24 and maintains a Hold rating due to lower-than-expected results and guidance [1] Group 1: Financial Performance - Management has reduced the guidance for the second half of the year to $25 million to $30 million, which is below the previous expectation of approximately $42 million [1] - There is an anticipated material recovery in bookings for the second half of the fiscal year, with shipments expected in FY27 [1]

Core Viewpoint - Aehr Test Systems experienced a boost in share price due to new orders for AI processor diagnostic products, which helped overshadow a disappointing quarterly earnings report [1] Group 1: New Orders - Aehr received over $5.5 million in orders for its Sonoma AI diagnostic systems from multiple customers, described as "leading-edge AI companies" and a "premier Bay Area lab" [2] - The current quarter's orders for Sonoma already exceed the total for the entire previous quarter [3] Group 2: Financial Performance - For the second quarter of fiscal 2026, Aehr's net revenue decreased to $9.9 million from $13.5 million year-over-year [4] - The company reported a net loss of $1.3 million, or $0.04 per share, compared to a profit of $700,000 in the same period last year [4] Group 3: Future Guidance - Aehr reinstated its revenue guidance, expecting between $25 million to $30 million in revenue and a non-GAAP net loss of $0.05 to $0.09 per share for the second half of the fiscal year [5]

Core Insights - Aehr Test Systems, Inc. is a company based in Fremont, California, specializing in equipment for testing semiconductor chips and conducting burn-in tests to stress chips for reliability [1] Company Overview - Aehr Test Systems focuses on providing testing solutions for semiconductor chips, which are critical in the technology sector [1] Market Position - The company operates within the small- to mid-cap segment of the market, which is often overlooked by many investors, but it also occasionally examines large-cap companies to provide a broader market perspective [1]

Core Insights - Aehr Test Systems, Inc. is a company based in Fremont, California, specializing in equipment for testing semiconductor chips and conducting burn-in tests to stress chips [1] Company Overview - Aehr Test Systems focuses on small- to mid-cap companies, which are often overlooked by many investors, while also occasionally analyzing large-cap companies to provide a broader market perspective [1]